The current page will cease to exist as of June 2019. Data, information and documents related to our grants are now available on the Global Fund Data Explorer. Please use this platform.
Ghana has a special history with the Global Fund, being the first country to sign a Global Fund grant in 2002. Since then, the country has made great progress against HIV, TB and malaria. The country has maintained a low adult HIV prevalence, which declined from 1.8 percent in 2012 to 1.6 percent in 2015. Over the past 10 years, Ghana has achieved 50 percent and 65 percent reductions in malaria in-patient cases and deaths. From 2014-2017, 17.75 million mosquito nets were distributed in the country through Global Fund support. TB treatment success rates has been high and steady, at more than 84 percent from 2010-2014. Additionally, multidrug-resistant TB case notification has increased from four in 2010 to 72 in 2015. However, more needs to be done. Only, an estimated 36 percent of people living with HIV were on antiretroviral therapy as of the end of 2016. Ghana aims to achieve the 90-90-90 fast-track treatment targets – 90 percent of people living with HIV know their HIV status, 90 percent of people who know their HIV-positive status are accessing treatment and 90 percent of people on treatment have suppressed viral loads – by 2020. Efforts to provide quality diagnosis and treatment of malaria also need to be sustained. And while TB incidence is the country has declined gradually in recent years, more work is needed to improve TB case detection rates, which remain a low 33 percent.
For documents pertaining to a specific grant, please select a grant from the list.